
Glaukos Corporation GKOS
€ 97.10
-0.93%
Quartalsbericht 2025-Q2
hinzugefügt 04.08.2025
Glaukos Corporation Langfristige Verbindlichkeiten 2011-2026 | GKOS
Langfristige Verbindlichkeiten Jährlich Glaukos Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 87.4 M | 2.74 M | 846 K | 159 K | 1.11 M | 9.36 M | 18.2 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 87.4 M | 159 K | 17.1 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | ||
|
Baxter International
BAX
|
7.05 B | $ 21.07 | 1.81 % | $ 10.7 B | ||
|
Becton, Dickinson and Company
BDX
|
25 B | $ 202.8 | -1.16 % | $ 58.3 B | ||
|
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
66.7 M | $ 151.86 | 0.14 % | $ 3.7 B | ||
|
iRhythm Technologies
IRTC
|
119 M | $ 180.4 | -4.68 % | $ 5.63 B | ||
|
Repro Med Systems
KRMD
|
239 K | $ 5.67 | -2.41 % | $ 259 M | ||
|
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | ||
|
Masimo Corporation
MASI
|
56 M | $ 140.04 | 1.54 % | $ 7.46 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | ||
|
Merit Medical Systems
MMSI
|
626 M | $ 86.37 | -7.31 % | $ 5.03 B | ||
|
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 8.03 | -1.95 % | $ 162 M | ||
|
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
6.05 B | $ 80.27 | -0.43 % | $ 40.4 B | ||
|
Predictive Oncology
POAI
|
236 K | $ 6.83 | 1.08 % | $ 37.2 M | ||
|
AtriCure
ATRC
|
261 M | $ 41.66 | -1.76 % | $ 1.96 B | ||
|
electroCore
ECOR
|
1.42 M | $ 5.62 | 11.73 % | $ 31 K | ||
|
Haemonetics Corporation
HAE
|
405 M | $ 82.2 | -2.19 % | $ 4.14 B | ||
|
AngioDynamics
ANGO
|
148 M | $ 9.97 | -0.8 % | $ 407 M | ||
|
Harvard Bioscience
HBIO
|
58.5 M | $ 0.64 | -1.79 % | $ 27.1 M | ||
|
The Cooper Companies
COO
|
1.54 B | $ 83.71 | 0.69 % | $ 16.7 B | ||
|
LeMaitre Vascular
LMAT
|
19.3 M | $ 84.83 | -0.25 % | $ 1.9 B | ||
|
InfuSystem Holdings
INFU
|
35 M | $ 8.61 | -4.01 % | $ 178 M | ||
|
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | ||
|
Nephros
NEPH
|
1.61 M | $ 4.89 | -2.5 % | $ 50.8 M | ||
|
Utah Medical Products
UTMD
|
5.25 M | $ 59.83 | 1.87 % | $ 217 M | ||
|
Intuitive Surgical
ISRG
|
418 M | $ 587.18 | 0.36 % | $ 209 B | ||
|
Microbot Medical
MBOT
|
760 K | $ 2.08 | -5.02 % | $ 21.2 M | ||
|
Milestone Scientific
MLSS
|
1.4 M | $ 0.3 | 1.23 % | $ 23.9 M | ||
|
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
1.91 B | $ 23.57 | -0.23 % | $ 4.06 B | ||
|
OraSure Technologies
OSUR
|
35.8 M | $ 2.63 | -1.13 % | $ 196 M | ||
|
Pro-Dex
PDEX
|
9.93 M | $ 41.51 | 0.51 % | $ 136 M | ||
|
Pulse Biosciences
PLSE
|
6.72 M | $ 14.63 | -0.61 % | $ 703 M | ||
|
Repligen Corporation
RGEN
|
701 M | $ 166.85 | 0.26 % | $ 9.3 M | ||
|
ResMed
RMD
|
1.05 B | $ 252.15 | 0.49 % | $ 36.8 B | ||
|
BioLife Solutions
BLFS
|
41.7 M | $ 24.8 | -0.6 % | $ 1.14 B | ||
|
STERIS plc
STE
|
1.53 B | $ 258.0 | -1.03 % | $ 25.4 B | ||
|
Stereotaxis
STXS
|
1.65 M | $ 2.53 | -2.13 % | $ 204 M | ||
|
Retractable Technologies
RVP
|
2.38 M | $ 0.76 | -2.53 % | $ 22.8 M | ||
|
STAAR Surgical Company
STAA
|
12.5 M | $ 22.06 | -1.96 % | $ 1.08 B | ||
|
Teleflex Incorporated
TFX
|
2.77 B | $ 112.75 | 2.49 % | $ 5.28 B | ||
|
West Pharmaceutical Services
WST
|
427 M | $ 275.51 | 0.1 % | $ 20.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 12.76 | 2.2 % | $ 2.59 B |